Protocol 0000498 is a multi center, open label study to evaluate the safety, tolerability and fat absorption of sustained Relizorb (immobilized lipase cartridge) use for patients with cystic fibrosis and exocrine pancreatic insufficiency who receive enteral tube feeding.